CombiMatrix (NASDAQ: CBMX) announced the launch of CombiPGS, a preimplantation genetic screening (PGS) test for women undergoing in vitro fertilization ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE